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Background: Peripheral arterial disease (PAD) is not just a limb threatening condition but an indication of a life threatening systemic vascular 
disease. Previous studies have shown that presence of PAD increases mortality by four fold and revascularization procedures reduce mortality by 
50%. Our study was designed to evaluate the out come of catheter based revascularization for PAD and compare multi vessel PAD (MVPAD) with 
single vessel PAD (SVPAD)
Methods: A retrospective observational study was conducted in a university hospital on 403 patients who had undergone catheter based 
revascularization for symptomatic PAD and evaluated all cause mortality at the end of 5 years. Data were collected from electronic medical records. 
Student t test and Chi-Square test were performed to compare MVPAD with SVPAD; Cox regression analysis to identify independent predictors for 
mortality.
Results: From a total of 403 patients who had undergone catheter based revascularization 158 patients (39.2%) had MVPAD (two or more 
vessels). Base line characteristics of SVPAD and MVPAD are: mean age 69± 12 years and 73± 11 years (p=0.0003), male gender 140(57%) and 
78(49%) (p=0.115), Caucasian ethnicity 135(55%) and 96(61%) (p=0.26), Diabetes mellitus (DM) 77(31%) and 53(34%) (p=0.65), coronary artery 
disease (CAD) 156(64%) and 87 (55%) (p=0.084%), history of cerebro vascular accident 34(14%) and 12 (8%) (p=0.053), smoking 74(30%) and 
36(23%) (p=0.102) respectively. All cause mortality at the end of 5 post procedural year was 73(30%) in SVPAD and 63(40%) in MVPAD (p=0.036). 
The independent predictors of increased mortality in MVPAD group are DM (HR: 1.6, CI 1.12-2.24, p=0.009) and CAD (HR: 1.5, CI 1.04-2.18, 
p=0.03).
Conclusion: MVPAD has significantly high five year mortality even after successful catheter based revascularization and optimum medical 
therapy compared to SVPAD indicating the necessity of further interventions for prevention and treatment of MVPAD. Presence of DM and CAD, each 
increases the risk of mortality by 1.5 times in this high risk group.
